← Back to Search

NDPP Presessions for Prediabetes

N/A
Waitlist Available
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Known to have diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial found that an innovative pre-session enhancement to the National Diabetes Prevention Program (NDPP) called Pre-NDPP was successful in doubling attendance and weight loss outcomes as compared to previous NDPP participants who did not receive a pre-session.

Who is the study for?
This trial is for Denver Health patients who have had prediabetes, gestational diabetes, or are at risk based on a screening tool. Participants must have a BMI of 25 or more (23 if Asian), and be able to communicate in English or Spanish. Those with diagnosed diabetes or pregnant women cannot join.
What is being tested?
The study tests an enhancement to the National Diabetes Prevention Program called Pre-NDPP, which aims to improve attendance and weight loss outcomes among diverse low-income populations at risk for type 2 diabetes.
What are the potential side effects?
Since this intervention involves educational sessions rather than medication, typical drug side effects are not expected. However, participants may experience lifestyle changes due to diet and exercise adjustments.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Weight loss
Secondary study objectives
Attendance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pre-NDPPExperimental Treatment2 Interventions
Presessions + usual care NDPP
Group II: Usual care NDPPActive Control1 Intervention
Usual care NDPP only

Find a Location

Who is running the clinical trial?

Denver Health and Hospital AuthorityLead Sponsor
104 Previous Clinical Trials
401,637 Total Patients Enrolled
University of Colorado, DenverOTHER
1,808 Previous Clinical Trials
2,821,757 Total Patients Enrolled

Media Library

National Diabetes Prevention Program Clinical Trial Eligibility Overview. Trial Name: NCT04022499 — N/A
Prediabetes Research Study Groups: Pre-NDPP, Usual care NDPP
Prediabetes Clinical Trial 2023: National Diabetes Prevention Program Highlights & Side Effects. Trial Name: NCT04022499 — N/A
National Diabetes Prevention Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04022499 — N/A
~76 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top